4th Quarter - Termination

FAEGRE BAKER DANIELS CONSULTING for MYRIAD GENETICS, INC.

Firm
Client
Income
—
Expenses
—
Terminated
Oct 31, 2019

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests.

LobbyistCovered position, as disclosed
JOHN KEVIN BRENNAN Chief of Staff, Rep. Rosa DeLauro (D-CT); Legislative Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA)
MEGAN SUSSMAN HERBER Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4302 (116th)

Medical/Disease Research/Clinical Labs MED

Draft legislation to regulate clinical labs under CLIA and FDA.

LobbyistCovered position, as disclosed
JOHN KEVIN BRENNAN Chief of Staff, Rep. Rosa DeLauro (D-CT); Legislative Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA)
MEGAN SUSSMAN HERBER Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.